Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Vipadenant demonstrates strong oral activity in commonly used models of Parkinson's disease
and the Kd for recombinant UCHL5 is higher (14-18 μM) compared to that of USP14
With limited ability to cross the blood–brain barrier
InChiKey: IDBWWEGDLCFCTD-VNEMRZQUSA-N
InChi: InChI=1S/C30H38FN3O2
Granisetron Hydrochloride - CAS# 107007-99-8 10549 Vipadenant demonstrates strong oral activityGranisetron hydrochloride is the hydrochloride salt of an indazole derivative with antiemetic properties. As a selective serotonin receptor antagonist, granisetron competitively blocks the action of serotonin at 5 hydroxytryptamine3 (5 HT3) receptors, resulting in the suppression of chemotherapy and radiotherapy induced nausea and vomiting. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus). Product
US$ 40.00
US$ 672.98
US$ 129.50
US$ 31.95
US$ 25.00
US$ 11.31